Tumor biology: molecular genetics mechanisms of initiation, promotion and progression
DOI:
https://doi.org/10.12775/JEHS.2022.12.11.050Keywords
tumor, carcinogenesis, malignant tumors, oncogenesAbstract
For all tumors, regardless of type and tissue, there are a number of common features. These include high proliferative activity, disturbances in the mechanisms of apoptosis and "invisibility" for the cells of the immune system. At the basis of all these disorders lies a malfunction in the interaction between signaling proteins inside the cell, due to a violation of the expression of genes responsible for their synthesis. The aim of the review is to study the molecular biological mechanisms of carcinogenesis, characteristics and features of tumor cells that affect the development of the disease, progression, drug resistance and clinical results and the possibilities of targeted therapy of oncological diseases. Material and methods. The search for literature sources was carried out using PubMed, CyberLeninka, eLibrary, Google Scholar databases; the search depth was 15 years. Results. Recent works have shown the evolution of views on the classification of tumors from the point of view of the mechanisms of damage to the processes of cellular regulation and histogenesis, as well as the development of the modern theory of carcinogenesis, ideas about the mechanisms of development of tumor diseases and the prospects of modern therapies. Conclusion. The study of molecular biological mechanisms of carcinogenesis, characteristics and features of tumor cells is not only fundamental, but also of applied importance in order to predict the development of the disease, progression, drug resistance, clinical results and the possibilities of targeted therapy.
References
Lemaire J., Larrue R., Perrais M., Cauffiez C., Pottier N. Aspects fondamentaux du développement tumoral [Fundamental aspects of oncogenesis]. Bull. Cancer . 2020; 107(11):1148-1160. [In French]. doi:10.1016/j.bulcan.2020.08.004
Jacqueline C., Biro, P., Beckmann, C., Moller, A., Renaud, F., Sorci, G., Tasiemski, A., Ujvari, B., Thomas, F. Cancer: a disease at the crossroads of trade-offs. Evol. Appl. 2016; 10(3). doi:10.1111/eva.12444
Gambhir N., Harris SD, Everhart SE Evolutionary Significance of Fungal Hypermutators: Lessons Learned from Clinical Strains and Implications for Fungal Plant Pathogens. mSphere . 2022;7(3):e0008722. doi:10.1128/msphere.00087-22
Ovsepyan V.A., Rosin V.A., Zagoskina T.P. Possible association of gene polymorphism of xenobiotic biotransformation enzymes with the features of the clinical course of chronic lymphocytic leukemia. Clinical oncohematology. Basic Research and Clinical Practice . 2011; 4(4): p. 279-285.
Ovsepyan VA, Rosin VA, Zagoskina TP Possible association of gene polymorphism of xenobiotic biotransformation enzymes with the clinical course of chronic lymphocytic leukemia. Clinical onkogematology. Fundamental'nye issledovaniya i klinicheskaya praktika = Clinical oncohematology. Basic research and clinical practice . 2011; 4(4): pp. 279-285. [In Russian].
Turnpenny PD, Ellard S., Cleaver R. Emery's Elements of Medical Genetics and Genomics. 15th _ ed . Elsevier; 2017 . p.184-209 .
Efimova I.Yu., Gevorkyan Yu.A., Soldatkina N.V., Milakin A.G. Clinical and genetic aspects of hereditary colon cancer. Familial adenomatous polyposis. Modern problems of science and education . 2017; 5:79.
Efimova I.Yu., Gevorkyan Yu.A., Soldatkina NV, Milakin AG Clinical and genetic aspects of hereditary colon cancer. Familial adenomatous polyposis. Modern problems of science and education. Modern problems of science and education. 2017; 5: 79. [In Russian].
Semyanikhina A.V., Pospekhova N.I., Filippova M.G., Golovina D.A., Rasulov A.O., Lyubchenko L.N. Clinical anamnestic and molecular genetic criteria for Lynch syndrome. Advances in molecular oncology. 2019;6(4):38-46. [In Russian].
Sem'yanikhina AV, Pospehova NI, Filippova MG, Golovina DA, Rasulov AO, Lyubchenko LN Clinical-anamnestic and molecular-genetic criteria of Lynch syndrome . Uspekhi molekulyarnoy onkologii = Advances in molecular oncology. 2019;6(4):38-46. .[In English].
Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. breast cancer. 2021; 28(6):1167-1180. doi:10.1007/s12282-020-01148-2
Valdez JM, Nichols KE, Kesserwan C. Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition. Br . J. _ Haematol. 2017; 176(4):539-552. doi:10.1111/bjh.14461
Severskaya N.V., Polyakov V.G., Shishkov R.V., Ilyin A.A., Ivanova N.V., Pavlovskaya A.I., Kozlova V.M., Amosenko F.A., Lyubchenko L. .N., Kazubskaya T.P., Koshechkina N.A., Mikhailova E.V., Matveeva I.I., Serebryakova I.N., Mikhailova S.N., Kalinchenko N.Yu. Three germline mutations in the RET gene in members of the same family with type 2A multiple endocrine neoplasia syndrome. Problems of endocrinology. 2016;62(6):28-32.
Severskaya NV, Polyakov VG, Shishkov RV, Ilyin AA, Ivanova NV, Pavlovskaya AI, Kozlova VM, Amosenko FA, Lyubchenko LN, Kazubskaya TP, Koshechkina NA, Mikhailova EV, Matveeva II, Serebryakova IN, Mikhailova SN, Kalinchenko N.Iu. Three RET germ - line mutations in a family with multiple endocrine neoplasia type 2 A syndrome . Problemy Endokrinologii = Problems of endocrinology . 2016; 62(6):28 - 32. [In Russian]. doi:10.14341/probl201662628-32
Larina I.I., Platonova N.M., Troshina E.A., Roslyakova A.A., Beltsevich D.G., Selivanova L.S., Yukina M.Yu., Nikankina L.V., Malysheva N .M., Tyulpakov A.N., Kovalevich L.D. Von Hippel-Lindau syndrome: features of treatment and observation. Clinical case and a brief review of the literature. Archive of internal medicine. 2019; 9(3): 165-171. doi : 10.20514/2226-6704-2019-9-3-165-171
Larina I. _ I ., Platonova N. _ M. , Troshina E. _ A ., Roslyakova A. _ A. , Bel'tsevich _ _ D. _ G. , Selivanova L. _ S. , Yukina M. _ Yu ., Nikankina L. _ V ., Malysheva N. _ M. , Tyul'pakov _ _ A. _ N ., Kovalevich L. _ D. _ On Hippel - Lindau Syndrome : Aspects of treatment and Management . Case Report and Literature Review. Arkhiv" vnutrenney meditsiny = The Russian Archives of Internal Medicine . 2019; 9(3):165-171. [In Russian]. doi: 10.20514/2226-6704-2019-9-3-165-171
Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. cell. 2011; 144(5):646-74. doi: 10.1016/j.cell.2011.02.013
Farmakovskaya M.D., Khromova N.V., Rybko V.A., Kopnin P.B. The role of the epithelial-mesenchymal transition in the regulation of the properties of cancer stem cells in solid tumors. Russian biotherapeutic journal . 2015 ; 14(4), 3-8 . doi: 10.17650/1726-9784-2015-14-4-3-8
Farmakovskaya MD, Khromova NV, Rybko VA, Kopnin PB The Role of Epithelial-Mesenchymal Transition in Regulation of Solid Tumors Cancer Stem Cells Characteristics. R Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy . 2015; 14(4):3-8. [In Russian]. doi: 10.17650/1726-9784-2015-14-4-3-8
Venerin A., VenerinaYa., Alexandrov Yu. Cell functioning in norm and pathology in terms of the activity paradigm: Oncogenesis. Medical Hypotheses . 2020; 144:110-240 doi:10.1016/j.mehy.2020.110240
Frank G.A., Andreeva Yu.Yu., Moskvina L.V., Efremov G.D., Samoilova S.I. New WHO classification of prostate tumors. Archive of pathology. 2016;78(4):32-42. doi : 10.17116/ patol 201678432-42
Frank GA, Andreeva Yu.Yu., Moskvina LV, Efremov GD, Samoilova SI A new WHO classification of prostate tumors. Arkhiv pathologii = Archive of Pathology. 2016; 78(4):32 - 42. [In Russian]. doi:10.17116/patol201678432-42
Yoshioka K.-I., Matsuno Y., Hyodo M., Fujimori H. Genomic-Destabilization-Associated Mutagenesis and Clonal Evolution of Cells with Mutations in Tumor-Suppressor Genes. Cancers (Basel). 2019; 11(11):1643. doi:10.3390/cancers11111643.
Lee JK, Choi YL, Kwon M., Park PJ Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies. Annu. Rev. Pathol . 2016; 11:283-312. doi:10.1146/annurev-pathol-012615-044446
Lyzhko N.A. Molecular genetic mechanisms of initiation, promotion and progression of tumors. Russian biotherapeutic magazine . 2017; 16(4):7-17 . doi:10.17650/1726-9784-2017-16-4-7-17
Lyzhko NA Molecular-genetic mechanisms of initiation, promotion and progression of tumors. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy. 2017; 16(4):7-17. [In Russian]. doi:10.17650/1726-9784-2017-16-4-7-17
Vysotskaya I.V., Letyagin V.P., Shabanov M.A., Kirsanov V.Yu., Kim E.A., Levkina N.V. Topical issues of carcinogenesis. Clinical oncohematology . 2019;12(1):101–6. doi: 10.21320/2500-2139-2019-12-1-101-106
Vysotskaya IV, Letyagin VP, Shabanov MA, Kirsanov V.Yu., Kim EA, Levkina NV Current issues of carcinogenesis. Clinical onkogematology = clinical oncohematology. 2019;12(1):101–6. [In Russian]. doi: 10.21320/2500-2139-2019-12-1-101-106
Kushlinsky N.E., Nemtsova M.V. Molecular and biological characteristics of malignant neoplasms. Herald RAMS . 2014; 69(1–2):5–15 doi:10.15690/vramn.v69i1-2.934
Kushlinskii NE, Nemtsova MV Molecular biological characteristics of cancer. Vestnik RAMN =Annals of the Russian academy of medical sciences. 2014; 69(1–2):5–15. [In Russian]. doi:10.15690/vramn.v69i1-2.934
Ruth JR, Pant DK, Pan TC, Seidel HE, Baksh SC, Keister BA, Singh R., Sterner Ch.J., Bakewell SJ, Moody SE, Belka GK, Chodosh LA Cellular dormancy in minimal residual disease following targeted therapy. Breast Cancer Res . 2021; 23(1):63. doi: 10.1186/s13058-021-01416-9.
Egeblad M., Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. dev. cell . 2010; 18(6):884–901. doi: 10.1016/j. devcel.2010.05.012.
Fernandez A., Esteller M. Viral epigenomes in human tumorigenesis. Oncogene. 2010; 29(10):1405–20. doi:10.1038/onc.2009.517
Junttila MR, Evan GL p53 – a Jack-Of-All-Trades but master of none. Nat. Rev. Cancer . 2009; 9(11); 821–9. doi: 10.1038/nrc2728.
Pleshkan V.V., Alekseenko I.V., Zinovieva M.V., Vinogradova T.V., Sverdlov E.D. Promoters with specific activity in cancer cells in melanoma gene therapy. Acta Naturae . 2011; 3(2):14–23.
Pleshkan VV, Alekseenko IV, Zinov'eva MV, Vinogradova TV, Sverdlov ED Promoters with cancer cell-specific activity for melanoma gene therapy. Acta Naturae . 2011;3(2):14–23. [In Russian].
Kovaleva O.V., Nazarova O.R., Matveev V.B., Grachev A.N. Molecular features of renal cell carcinoma: early diagnosis and prospects for therapy. Advances in molecular oncology. 2014;1(2):36–43. doi:10.17650/2313-805X.2014.1.2.36-43
Kovaleva OV, Nazarova OR, Matveev VB, Grachev AN Molecular features of renal cell carcinoma: early diagnosis and perspectives for therapy. Uspekhi molekulyarnoi onkologii = Advances in Molecular Oncology . 2014; 1(2):36–43. [In Russian]. doi:10.17650/2313-805X.2014.1.2.36-43
Berger AH, Knudson AG, Pandolfi PP A continuum model for tumor suppression. Nature. 2011; 476(7359):163–9. doi: 10.1038/nature10275.
Chen Y., Fu LL, Wen X., Liu B., Huang J., Wang JH, Wei YQ Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy. Apoptosis: an international journal on programmed cell death. 2014; 19(8), 1177-1189. doi:10.1007/s10495-014-0999-7
Berdasco M., Esteller M. Aberrant epigenetic landscape in cancer: how cellular identity goes awry. dev. cell . 2010; 19(5):698–711. doi: 10.1016/j. devcel.2010.10.005
Hudler P. Genetic Aspects of Gastric Cancer Instability. The Scientific World Journal [Internet].2012 [cited 2015 Jan. 01]. Available from: http://www.hindawi.com/journals/tswj/2012/761909/
Kharchenko E.P. Some immunological aspects of carcinogenesis. Oncology. Journal them. P.A. Herzen . 2013;2(5):70-76.
Kharchenko EP. Some immunological aspects of carcinogenesis. Onkology. Journal im. PA Gertsena = PA Herzen Journal of Oncology. 2013;2(5):70-76. [In Russian].
Bindea G., Mlecnik B., Fridman WH Natural immunity to cancer in humans. Curr. Opin. Immunol. 2010; 22(2):215–22. doi: 10.1016/j.coi.2010.02.006.
Grivennikov S., Greten FR, Karin M. Immunity, infl ammation and cancer. cell. 2010; 140(6):883–99. doi: 10.1016/j.cell.2010.01.025.
Pastushenko I., Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol . 2019; 29(3):212-226. doi: 10.1016/j.tcb.2018.12.001.
Petrova YI, Schecterson L., Gumbiner BM Roles for E-cadherin cell surface regulation in cancer. Mol. Biol. cell . 2016; 27(21):3233-3244. doi: .1091/mbc.E16-01-0058.
Vishwakarma R., McManus KJ Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes. Cancers (Basel). 2020; 12(4):824. doi:10.3390/cancers12040824
Derizhanova I.S. Metaplasia of epithelial tissues: modern concepts (on the example of intestinal metaplasia of the mucous membrane of the stomach and esophagus). Journal of Basic Medicine and Biology . 2012; 3 : 23-30.
Derizhanova IS Epithelial tissue metaplasia: current views (on the example of intestinal metaplasia of the gastric mucosa and esophagus). Zhurnal fundamental'noy meditsiny i biologii = Journal of Fundamental Medicine and Biology . 2012; 3:23-30. [In Russan].
Correa M., Piazuelo B. The gastric precancerous cascade . J. Dig. Dis. 2012; 13(1): 2-9. doi: 10.1111/j.1751-2980.2011.00550.x.
Tomasetti C., Li L., Vogelstein B. Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. science . 2017; 355(6331):1330-1334. doi: 10.1126/science.aaf9011.
Martincorena I., Fowler JC, Wabik A., Lawson ARJ, Abascal F., Hall MWJ, Cagan A., Murai K., Mahbubani K., Stratton MR, Fitzgerald RC, Handford PA.., Campbell PJ., Saeb- Parsy K, Jones PH Somatic mutant clones colonize the human esophagus with age. Science. 2018; 362(6417):911-917. doi: 10.1126/science.aau3879.
Yokoyama A., Kakiuchi N., Yoshizato T., Nannya Y., Suzuki H., Takeuchi Y., Shiozawa Y., Sato Y., Aoki K., Kim SK, Fujii Y., Yoshida K., Kataoka K. , Nakagawa MM, Inoue Y., Hirano T., Shiraishi Y., Chiba K., Tanaka H., Sanada M., Nishikawa Y., Amanuma Y., Ohashi S., Aoyama I., Ogawa S. Age-related remodeling of oesophageal epithelia by mutated cancer drivers. nature . 2019; 565(7739):312-317. doi: 10.1038/s41586-018-0811-x.
Martincorena I., Roshan A., Gerstung M., Ellis P., Loo PV, McLaren S., Wedge DC, Fullam A., Alexandrov LB, Tubio JM, Stebbings L., Menzies A., Widaa S., Stratton MR , Jones Ph.H., Campbell PJ Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015; 348(6237):880-886. doi: 10.1126/science.aaa6806.
Matsuno Y., Atsumi Y., Shimizu A., Katayama K., Fujimori H., Hyodo M., Minakawa Y., Nakatsu Y., Kaneko S., Hamamoto R., Shimamura T., Miyano S., Tsuzuki T ., Hanaoka F., Yoshioka KI Replication stress triggers microsatellite destabilization and hypermutation leading to clonal expansion in vitro. NatCommun . 2019; 10(1):3925. doi:10.1038/s41467-019-11760-2
Yoshioka K.-i., Matsuno Y., Hyodo M., Fujimori H. Genomic-Destabilization-Associated Mutagenesis and Clonal Evolution of Cells with Mutations in Tumor-Suppressor Genes. Cancers 2019, 11, 1643; doi:10.3390/cancers11111643
Biron-Shental T., Liberman M., Sharvit M., Sukenik-Halevy R., Amiel A. Amniocytes from aneuploidy embryos have enhanced random aneuploidy and signs of senescence – can these findings be related to medical problems? Gene. 2015; 562(2):232-235. doi: 10.1016/j.gene.2015.02.075
Nicholson JM, Macedo JC, Mattingly AJ, Wangsa D., Camps J., Lima V., Gomes AM, Dória S., Ried T., Logarinho E., Cimini D. Chromosome mis-segregation and cytokinesis failure in trisomic human cells . elife. 2015; 4:e05068. doi: 10.7554/eLife.05068.
Zhu, J.; Tsai, HJ; Gordon, M.R.; Li, R. Cellular Stress Associated with Aneuploidy. dev cell. 2018; 44(4):420-431. doi: .1016/j.devcel.2018.02.002.
Haron NH, Mohamad Hanif EA, Abdul Manaf MR, Yaakub JA, Harun R., Mohamed R., Rose IM Microsatellite Instability and Altered Expressions of MLH1 and MSH2 in Gastric Cancer. Asian Pac J Cancer Prev . 2019; 20(2):509-517. doi:10.31557/APJCP.2019.20.2.509
Belkovets A.V., Reshetnikov O.V., Kurilovich S.A., Maksimov V.N. Gastric cancer: modern molecular genetic data (literature review). Siberian journal of oncology . 2014 ; 2(62) : 56-64.
Belkovec AV, Reshetnikov OV, Kurilovich SA, Maksimov VN Gastric cancer: modern molecular genetic data (literature review). Siberian journal of oncology 2014;2(62): 56-64. [In Russian].
Chopra A. [99mTc] Human telomerase reverse transcriptase antisense mRNA oligonucleotide. In: Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD): National Center for Biotechnology Information (US); 2008.
Carlomagno N., Incollingo P., Tammaro V., Peluso G., Rupealta N., Chiacchio G., Sandoval Sotelo ML, Minieri G., Pisani A., Riccio E., Sabbatini M., Bracale UM, Calogero A. , Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017: 7869802. doi:10.1155/2017/7869802
Chen T., Xu XY, Zhou PH Emerging molecular classifications and therapeutic implications for gastric cancer. Chin. J. Cancer. 2016; 35:49. doi:10.1186/s40880-016-0111-5
Bibi F., Ali I., Naseer MI, Ali Mohamoud HS, Yasir M., Alvi SA, Jiman-Fatani AA, Sawan A., Azhar EI Detection of genetic alterations in gastric cancer patients from Saudi Arabia using comparative genomic hybridization (CGH ). PLOS One. 2018; 13(9):e0202576. doi: 10.1371/journal.pone.0202576.
Sharma B., Angurana S., Bhat A., Verma S., Bakshi D., Bhat GR, Jamwal RS, Amin A., Qadri RA, Shah R., Kumar R. Genetic analysis of colorectal carcinoma using high throughput single nucleotide polymorphism genotyping technique within the population of Jammu and Kashmir. Mol. Biol. Rep . 2021; 48(8):5889-5895. doi: 10.1007/s11033-021-06583-8.
Lichtenstein AV Cancer research: a hurdle race. Biochemistry (Mosc). 2014; 79(5):385-90. doi:10.1134/S0006297914050010
Ma C., Xie JW, Kuang AR, Huang R., Tang GS The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells. Sichuan Da Xue Xue Bao Yi Xue Ban . 2009; 40(5):780-3. Chinese.
Lucianò AM, Pérez-Oliva AB, Mulero V., Del Bufalo D. Bcl-xL: A Focus on Melanoma Pathobiology. Int. J. Mol. Sci . 2021; 22(5):2777. doi: 10.3390/ijms22052777.
Velcheti V., Schalper K. Basic Overview of Current Immunotherapy Approaches in Cancer. American Society of Clinical Oncology Educational Book. 2016; 35:298-308. doi:10.1200/EDBK_156572
Smirnova O.V., Borisov V.I. Immunotherapy in drug treatment of patients with metastatic triple negative breast cancer. Oncology . Magazine them . P . A . Herzen . 2018; 7(6):60-66. doi:10.17116/onkolog2018706160
Smirnova OV, Borisov VI Immunotherapy in the drug treatment of patients with triple-negative metastatic breast cancer. Onkology. Journal im. PA Gertsena = PA Herzen Journal of Oncology. 2018; 7(6):60-66. [In Russian]. doi:10.17116/onkolog2018706160
Kashyap AS, Thelemann T., Klar R., Kallert SM, Festag J., Buchi M., Hinterwimmer L., Schell M., Michel S., Jaschinski F., Zippelius A. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. J. Immunother. cancer. 2019 ; Mar 12; 7(1):67. doi:10.17116/onkolog2018706160 10.1186/s40425-019-0545-9.
Nagini S. Breast Cancer: Current Molecular Therapeutic Targets and New Players. Anticancer Agents Med. Chem . 2017; 17(2):152-163. doi:10.2174/1871520616666160502122724
Xiu B., Chi Y., Liu L., Chi W., Zhang Q., Chen J., Guo R., Si J., Li L., Xue J., Shao ZM, Wu ZH, Huang S., Wu J. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription. Mol. cancer. 2019; 18(1):187. doi: 10.1186/s12943-019-1115-y.
Sun Y., Yan L., Guo J., Shao J., Jia R. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment. Cancer Chemother. Pharmacol. 2019; 84(5):1133-1143. doi: 10.1007/s00280-019-03945-9.
Skvortsova YV, Salina EG, Burakova EA, Bychenko OS, Stetsenko DA, Azhikina TL A New Antisense Phosphoryl Guanidine Oligo-2′-O-Methylribonucleotide Penetrates Into Intracellular Mycobacteria and Suppresses Target Gene Expression. Frontiers in Pharmacology . 2019; 10 . doi: 10.3389/fphar.2019.01049
Juliano RL The delivery of therapeutic oligonucleotides. Nucleic Acids Research . 2016; 44(14):6518-48. doi:10.1093/nar/gkw236
Linnane E., Davey P., Zhang P., Puri S., Edbrooke M., Chiarparin E., Revenko AS, Macleod AR, Norman JC, Ross SJ Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines. Nucleic Acids Res . 2019; 47(9):4375-4392. doi:10.1093/nar/gkz214.
Zhou T., Jia X., Li H., Wang J., Zhang H., A Y., Zhang Z. New tumor-targeted nanosized delivery carrier for oligonucleotides: characteristics in vitro and in vivo. Int. J. Nanomedicine . 2011; 6:1527-34. doi:10.2147/IJN.S15239.
Moody TW, Nuche-Berenguer B., Jensen RT Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer. Curr Opin Endocrinol Diabetes Obes . 2016;23(1):38-47. doi: 10.1097/MED.0000000000000218.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Elizaveta Ageeva, Elena Golubinskayaa, Tatyana Makalish, Iryna Fomochkina, Anatolii Kubyshkin, Walery Zukow, Iuliana Shramko, Olga Ostapenko, Anna Zhukova, Anna Gurtovaya
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 404
Number of citations: 0
